Question Title

* 1. CME CREDIT REQUEST
The Pacific Northwest Gastroenterology Society (PNWGS) is accredited by the Washington State Medical Association to provide continuing medical education. The PNWGS designates this activity for a maximum of 9 AMA PRA Category 1 Credits™. Learners should claim only the credit commensurate with the extent of their participation in the activity. For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™. One Credit = One CEU as AMA PRA Category 1 Credits are a one-to-one conversion.

Question Title

* 2. Session 1, Lecture 1 - Pediatric Endoscopy by Travis Piester, M.D.: Was today's lecture content relevant to your work and/or practice?

Question Title

* 3. Session 1, Lecture 1 - Pediatric Endoscopy by Travis Piester, M.D.: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 4. Session 1, Lecture 1: Pediatric Endoscopy by Travis Piester, M.D. ~ Learning Objectives:
  • Pediatric Endoscopy – Unique Elements: Describe unique indications and considerations for pediatric endoscopy
  • Interventional Endoscopy in Pediatrics: Characterize barriers and the current state of pediatric interventional endoscopy
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 5. Session1, Lecture 2: GLP-1 Agonists - Should Endoscopy "Weight"? by Harry L. Teicher, M.D.: Was today's lecture content relevant to your work and/or practice?

Question Title

* 6. Session 1, Lecture 2: GLP-1 Agonists - Should Endoscopy "Weight"? by Harry L. Teicher, M.D.: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 7. Session 1, Lecture 2: GLP-1 Agonists - Should Endoscopy "Weight"? by Harry L. Teicher, M.D.: ~ Learning Objectives:
  • Recognize names and describe physiological effects of GLP-1 agonists and their effects over time.
  • Understand rationale for 2023 ASA endoscopy recommendations regarding GLP-1 agonists.
  • Discovering areas for future research regarding safety of GLP-1 agonists for patients undergoing endoscopic procedures.
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 8. Session1, Lecture 3: Advanced Closure by Nishant Puri, M.D. Was today's lecture content relevant to your work and/or practice?

Question Title

* 9. Session 1, Lecture 3: Advanced Closure by Nishant Puri, M.D.: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 10. Session 1, Lecture 3: Advanced Closure by Nishant Puri, M.D.: ~ Learning Objectives:
  • Understand deep mural injury and describe various tools and techniques to close them according to their size and location
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 11. Session 1, Lecture 4: Interventional Pulmonary by Jiten D. Patel, M.D.: Was today's lecture content relevant to your work and/or practice?

Question Title

* 12. Session 1, Lecture 4: Interventional Pulmonary by Jiten D. Patel, M.D.: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 13. Session 1, Lecture 4: Interventional Pulmonary by Jiten D. Patel, M.D. ~ Learning Objectives:
  • Identify new modalities to diagnose lung nodule(s)
  • Basic understanding of lung cancer staging and the role for EBUS
  • Understand the role for rigid bronchoscopy
  • Recognize novel treatments for Asthma (BT) and COPD (LVRS)
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 14. Session 2, Lecture 1: Endohepatology by Divyanshoo R. Kohli, M.D.: Was today's lecture content relevant to your work and/or practice?

Question Title

* 15. Session 2, Lecture 1: Endohepatology by Divyanshoo R. Kohli, M.D.: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 16. Session 2, Lecture 1: Endohepatology by Divyanshoo R. Kohli, M.D. ~ Learning Objectives:
  • Understand the emerging role for Endo hepatology.
  • Recognize and discuss the best practices for EUS guided liver biopsies and portal pressure gradient measurements.
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 17. Session 2, Lecture 2: An Endoscopy Nurses’ Guide to Nutrition: A Review on the Evaluation of Malnutrition and Diet Based Therapy by Matthew S. Berger, M.D.: Was today's lecture content relevant to your work and/or practice?

Question Title

* 18. Session 2, Lecture 2: An Endoscopy Nurses’ Guide to Nutrition: A Review on the Evaluation of Malnutrition and Diet Based Therapy by Matthew S. Berger, M.D.: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 19. Session 2, Lecture 2: An Endoscopy Nurses’ Guide to Nutrition: A Review on the Evaluation of Malnutrition and Diet Based Therapy by Matthew S. Berger, M.D.~ Learning Objectives:
  • Identify and evaluate malnutrition. This will include understanding the definitions, physiology and pathophysiology of the fed, fasted and stressed state, how to perform a nutrition-focused physical exam and complete a nutrition assessment.
  • Review the high yield points and physiological concepts of diet based therapy for a variety of conditions including diverticular disease, gastroparesis, dumping syndrome, short gut syndrome, irritable bowel syndrome and inflammatory bowel disease
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 20. Session 2, Lecture 3: Liver Transplant for Alcoholic Hepatitis by Glen A. Lutchman M.D., MHSc: Was today's lecture content relevant to your work and/or practice?

Question Title

* 21. Session 2, Lecture 3: Liver Transplant for Alcoholic Hepatitis by Glen A. Lutchman M.D., MHSc: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 22. Session 3, Lecture 1: Liver Transplant for Alcoholic Hepatitis by Glen A. Lutchman M.D., MHSc ~ Learning Objectives:
  • Compare and contrast the differences between alcoholic hepatitis and alcoholic cirrhosis
  • Describe the rationale for transplanting patients with acute alcoholic hepatitis
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 23. Session 3, Lecture 1: Emotional Intelligence / Conflict Resolution by Kunjali T. Padhya, M.D.: Was today's lecture content relevant to your work and/or practice?

Question Title

* 24. Session 3, Lecture 1: Emotional Intelligence / Conflict Resolution by Kunjali T. Padhya, M.D.: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 25. Session 3, Lecture 1: Emotional Intelligence / Conflict Resolution by Kunjali T. Padhya, M.D. ~ Learning Objectives:
  • Define the components of emotional intelligence
  • Identify one strategy to self regulate emotion during a conflict 
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 26. Session 3, Lecture 2: Overnight GI Emergencies by Jennifer K. Kennedy, M.D.: Was today's lecture content relevant to your work and/or practice?

Question Title

* 27. Session 3, Lecture 2: Overnight GI Emergencies by Jennifer K. Kennedy, M.D.: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 28. Session 3, Lecture 2: Overnight GI Emergencies by Jennifer K. Kennedy, M.D. ~ Learning Objectives:
  • Recognize the common overnight GI emergencies and understand the risks of delayed intervention.
  • Increase familiarity with new tools to address GI bleeding and increase safety and effectiveness in foreign body removal.  
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 29. Session 3, Lecture 3: Trends in Early-Onset Colon Cancer: Why 45 is the New 50 by Naomi D. Chou, M.D.: Was today's lecture content relevant to your work and/or practice?

Question Title

* 30. Session 3, Lecture 3: Trends in Early-Onset Colon Cancer: Why 45 is the New 50 by Naomi D. Chou, M.D.: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 31. Session 3, Lecture 3: Trends in Early-Onset Colon Cancer: Why 45 is the New 50 by Naomi D. Chou, M.D. ~ Learning Objectives:
  • Recognize trends, epidemiology, characteristics, and risk factors of early-onset colon cancer.
  • Understand why the recommended age to start colon cancer screening was changed from 50 to 45 across all three major GI societies (American Gastroenterological Association, American Society of Gastrointestinal Endoscopy, American College of Gastroenterology).
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 32. Virtual Session, Lecture 1: Small Bowel Endoscopy by Christopher J. Carlson, M.D.: Was today's lecture content relevant to your work and/or practice?

Question Title

* 33. Virtual Session, Lecture 1: Small Bowel Endoscopy by Christopher J. Carlson, M.D.: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 34. Virtual Session, Lecture 1: Small Bowel Endoscopy by Christopher J. Carlson, M.D. ~ Learning Objectives:
  • Identify at least two different tools/techniques used in deep/small bowel enteroscopy.
  • Identify types of possible adverse events in small bowel enteroscopy.
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 35. Virtual Session, Lecture 2: Seeing Green: GI in 2024 by Rohit Sharda, M.D.: Was today's lecture content relevant to your work and/or practice?

Question Title

* 36. Virtual Session, Lecture 1: Seeing Green: GI in 2024 by Rohit Sharda, M.D.: Please evaluate this faculty member in regards to their effectiveness of teaching strategies.

Question Title

* 37. Virtual Session, Lecture 1: Seeing Green: GI in 2024 by Rohit Sharda, M.D. ~ Learning Objectives:
  • Understand the scope of the environmental impact of endoscopic procedures and procedural-related waste in the endoscopy unit.
  • Learn and apply strategies to foster a mindset shift among physicians and nurses, enabling them to critically evaluate and implement sustainable innovations in the endoscopy unit and in the hospital at large, thereby improving procedural efficiency while reducing our ecological footprint.
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 38. Breakout Sessions - Learning Objectives:
  • Discuss the disease state of the session and identify which treatment modality would work best for each indication.
  • Learn and understand advanced endoscopic devices and where they should be utilized in the treatment algorithm.
  • Recognize, diagnose, and anticipate clinical needs of provider to maximize efficiency of the procedure.
My ability to recognize and apply new research/knowledge in this area in order to adjust patient treatment plans appropriately has:

Question Title

* 39. Overall, please rate the extent to which the course learning objectives were met:

Question Title

* 40. Please provide your overall evaluation of the Endoscopy Course:

Question Title

* 41. Commercial interest" is defined as any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests.  

Did you perceive any bias toward a "commercial interest" in any presentation?

Question Title

* 42. What potential barriers do you anticipate encountering as you incorporate what you learned at this activity?   Please indicate specific changes you plan to implement in your professional or clinical practice as a result of this session:

Question Title

* 43. We appreciate your feedback on this year's event and would like to hear any suggestions you have for future topics, format, or improvements as we begin planning for next year!

T